230 related articles for article (PubMed ID: 33613107)
1. The association of Metabolic Syndrome and its Components with the Incidence and Survival of Colorectal Cancer: A Systematic Review and Meta-analysis.
Han F; Wu G; Zhang S; Zhang J; Zhao Y; Xu J
Int J Biol Sci; 2021; 17(2):487-497. PubMed ID: 33613107
[No Abstract] [Full Text] [Related]
2. Metabolic syndrome, its components, and gastrointestinal cancer risk: a meta-analysis of 31 prospective cohorts and Mendelian randomization study.
Zhan ZQ; Chen YZ; Huang ZM; Luo YH; Zeng JJ; Wang Y; Tan J; Chen YX; Fang JY
J Gastroenterol Hepatol; 2024 Apr; 39(4):630-641. PubMed ID: 38230882
[TBL] [Abstract][Full Text] [Related]
3. Association between metabolic syndrome and colorectal cancer incidence and all-cause mortality: a hospital-based observational study.
Chung KC; Juang SE; Chen HH; Cheng KC; Wu KL; Song LC; Lee KC
BMC Gastroenterol; 2022 Nov; 22(1):453. PubMed ID: 36368935
[TBL] [Abstract][Full Text] [Related]
4. Association between metabolic syndrome and its components and incident colorectal cancer in a prospective cohort study.
Tran TT; Gunathilake M; Lee J; Kim J
Cancer; 2022 Mar; 128(6):1230-1241. PubMed ID: 34762301
[TBL] [Abstract][Full Text] [Related]
5. The metabolic syndrome and its components as prognostic factors in colorectal cancer: A meta-analysis and systematic review.
Lu B; Qian JM; Li JN
J Gastroenterol Hepatol; 2023 Feb; 38(2):187-196. PubMed ID: 36287138
[TBL] [Abstract][Full Text] [Related]
6. Colorectal cancer association with metabolic syndrome and its components: a systematic review with meta-analysis.
Esposito K; Chiodini P; Capuano A; Bellastella G; Maiorino MI; Rafaniello C; Panagiotakos DB; Giugliano D
Endocrine; 2013 Dec; 44(3):634-47. PubMed ID: 23546613
[TBL] [Abstract][Full Text] [Related]
7. Metabolic syndrome and the risk of colorectal cancer: a systematic review and meta-analysis.
Shen X; Wang Y; Zhao R; Wan Q; Wu Y; Zhao L; Wu X
Int J Colorectal Dis; 2021 Oct; 36(10):2215-2225. PubMed ID: 34331119
[TBL] [Abstract][Full Text] [Related]
8. The combined effect of non-alcoholic fatty liver disease and metabolic syndrome on colorectal carcinoma mortality: a retrospective in Chinese females.
Chen ZF; Dong XL; Huang QK; Hong WD; Wu WZ; Wu JS; Pan S
World J Surg Oncol; 2018 Aug; 16(1):163. PubMed ID: 30097069
[TBL] [Abstract][Full Text] [Related]
9. Association between metabolic syndrome and early-stage colorectal cancer.
Zhang C; Zhang L; Tian Y; Guan B; Li S
BMC Cancer; 2023 Oct; 23(1):1020. PubMed ID: 37872512
[TBL] [Abstract][Full Text] [Related]
10. Metabolic syndrome and colorectal adenoma risk: A systematic review and meta‑analysis.
Wu H; Zhang J; Zhou B
Clin Res Hepatol Gastroenterol; 2021 Sep; 45(5):101749. PubMed ID: 34214702
[TBL] [Abstract][Full Text] [Related]
11. The relationship between metabolic syndrome and the incidence of colorectal cancer.
Lee J; Lee KS; Kim H; Jeong H; Choi MJ; Yoo HW; Han TH; Lee H
Environ Health Prev Med; 2020 Feb; 25(1):6. PubMed ID: 32075578
[TBL] [Abstract][Full Text] [Related]
12. Systematic review and meta-analysis: Associations between metabolic syndrome and colorectal neoplasia outcomes.
Lu L; Koo S; McPherson S; Hull MA; Rees CJ; Sharp L
Colorectal Dis; 2022 Jun; 24(6):681-694. PubMed ID: 35156283
[TBL] [Abstract][Full Text] [Related]
13. The association between metabolic syndrome and colorectal neoplasm: systemic review and meta-analysis.
Jinjuvadia R; Lohia P; Jinjuvadia C; Montoya S; Liangpunsakul S
J Clin Gastroenterol; 2013 Jan; 47(1):33-44. PubMed ID: 23090040
[TBL] [Abstract][Full Text] [Related]
14. Association between Mediterranean diet adherence and colorectal cancer: a dose-response meta-analysis.
Zhong Y; Zhu Y; Li Q; Wang F; Ge X; Zhou G; Miao L
Am J Clin Nutr; 2020 Jun; 111(6):1214-1225. PubMed ID: 32359135
[TBL] [Abstract][Full Text] [Related]
15. Colorectal cancer and its association with the metabolic syndrome: a Malaysian multi-centric case-control study.
Ulaganathan V; Kandiah M; Zalilah MS; Faizal JA; Fijeraid H; Normayah K; Gooi BH; Othman R
Asian Pac J Cancer Prev; 2012; 13(8):3873-7. PubMed ID: 23098486
[TBL] [Abstract][Full Text] [Related]
16. Association Between Metabolic Syndrome and the Risk of Colorectal Cancer Diagnosed Before Age 50 Years According to Tumor Location.
Jin EH; Han K; Lee DH; Shin CM; Lim JH; Choi YJ; Yoon K
Gastroenterology; 2022 Sep; 163(3):637-648.e2. PubMed ID: 35643169
[TBL] [Abstract][Full Text] [Related]
17. Specific features of colorectal cancer in patients with metabolic syndrome: a matched case-control analysis of 772 patients.
Zarzavadjian Le Bian A; Denet C; Tabchouri N; Donatelli G; Wind P; Louvet C; Bennamoun M; Christidis C; Perniceni T; Fuks D; Gayet B
Langenbecks Arch Surg; 2018 Jun; 403(4):443-450. PubMed ID: 29704123
[TBL] [Abstract][Full Text] [Related]
18. Association of gallstone disease with risk of colorectal cancer: a systematic review and meta-analysis of observational studies.
Polychronidis G; Siddiqi H; Ali Ahmed F; Papatheodorou S; Giovannucci EL; Song M
Int J Epidemiol; 2023 Oct; 52(5):1424-1434. PubMed ID: 37071919
[TBL] [Abstract][Full Text] [Related]
19. The Association Between Metabolic Syndrome and Colorectal Cancer Risk by Obesity Status in Korean Women: A Nationwide Cohort Study.
Moon SG; Park B
J Prev Med Public Health; 2022 Sep; 55(5):475-484. PubMed ID: 36229910
[TBL] [Abstract][Full Text] [Related]
20. Metabolic syndrome and liver-related events: a systematic review and meta-analysis.
Ren H; Wang J; Gao Y; Yang F; Huang W
BMC Endocr Disord; 2019 Apr; 19(1):40. PubMed ID: 31023282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
